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Human immunodeficiency virus (HIV) positive children are a tragic consequence of the HIV epidemic because they have acquired the infection from their HIV-positive 
mothers during pregnancy and have not had antiretroviral 
treatment (ART). It is not just the medical aspects, but their entire 
psychosocial development and the discrimination they suffer, 
that adds tremendous poignancy to the tragedy. It is, therefore, 
important to clarify the extent of the health problems in these 
children in terms of growth and development, both physical and 
mental. HIV infection can contribute to disturbances in linear 
growth and weight gain in the early childhood, often apparent 
as early as 3 months of age [1]. Published evidence from India 
is scarce.
A retrospective analysis on anemia and growth failure in 
HIV-infected children from one study in India states that 55% 
of HIV positive children were underweight and 46% had stunted 
growth [2]. Studies from developed countries have also shown 
a delay in growth and development [1]. Majaliwa et al. have 
reported that children with perinatal HIV infection may present 
with clinical features of endocrine dysfunction such as growth 
failure and pubertal delay [3]. It is likely that provision of ART 
may reverse the trends of growth failure as demonstrated in one 
study of Thai children [4]. However, there is a dearth of similar 
data in the Indian setting. There is little evidence for a difference 
in the early growth of HIV-exposed but uninfected children 
compared to healthy controls. Owing to the close association 
of growth with immune function and clinical progression, an 
understanding of growth patterns may be important to ensure the 
provision of appropriate care to HIV-infected and HIV-exposed 
children. Timely growth monitoring may be used to improve the 
clinical course and the quality of life of these children [1].
In this prospective study, an adequate sample of children who 
were infected with HIV was assessed and followed up over a 
period of 3 years to assess their physical growth, comparing them 
with an age-sex matched group of children who were exposed 
to HIV but were not infected. A third group for comparison was 
children who were HIV negative. The purpose of the study was 
to identify possible links between HIV infection and growth. 
ABSTRACT
Background: Children living with human immunodeficiency virus (CLHIV) are physically stunted and underweight compared 
to normal children. Objective: The aim of this study was to determine the physical growth (height, weight, and body mass 
index [BMI]) of children infected with HIV according to age, gender, sociodemographic factors, antiretroviral therapy (ART), 
and health status and to compare their physical growth with two other groups, i.e., exposed uninfected children and unexposed 
uninfected children and to determine the extent of growth retardation and the effect of ART on the reversal of growth retardation. 
Materials and Methods: A 3-year study on growth and development of CLHIV was conducted at Action, Service, Hope Foundation, 
a non-governmental institution working in the field of HIV/AIDS. Three groups of children were compared - 63 CLHIV, 98 exposed 
uninfected children, and 70 unexposed uninfected children. Their nutritional status in terms of weight for age, height for age, BMI, 
sexual maturity, hemoglobin, and serum albumin were compared. Results: Among CLHIV, 28.1% of children were underweight 
with Z score of <−2, compared to 12.5% of exposed uninfected children, and 14.3% unexposed uninfected children. Height for 
age Z scores showed 29.8% were stunted with Z score <−2 among CLHIV, with 16.7% and 11.4% among the exposed uninfected 
and unexposed uninfected, respectively. Statistically significant difference was also observed in Tanner’s sexual maturity with 
CLHIV showing slower sexual maturation. The incidence of anemia was highest among CLHIV and slightly higher in those on 
ART. Conclusions: This study shows that CLHIV are comparatively more stunted heightwise and have decreased weight for age, 
delayed sexual maturation, and more significant anemia when compared to exposed uninfected children and unexposed uninfected 
children. This physical growth retardation is not reversed completely by addition of ART.
Key words: Anti-retroviral treatment, Children living with human immunodeficiency virus, Development, Growth, Stunted, 
Underweight
Vol 4 | Issue 2 | Apr - Jun 2017 Indian J Child Health 163
Alexander et al. Growth and development of children living with human immunodeficiency virus
This 3-year study was funded by the Indian Council of Medical 
Research and conducted at Action, Service, Hope (ASHA 
for AIDS) Foundation, a Non-Governmental Organization in 
Bengaluru that has been working in the field of HIV/AIDS since 
1998.
MATERIALS AND METHODS
This was a 3-year prospective cohort study of children who were 
followed up at the ASHA Foundation with a nested case-control 
study of children living with HIV (CLHIV). This group was 
designated as Group 1. This group was compared to age - and 
sex - matched HIV-exposed uninfected children (Group 2) and 
HIV unexposed uninfected children (Group 3).
The total number of children enrolled for the study was 231 as 
demonstrated in Fig. 1 Group 1 consisted of HIV-infected children. 
Of these, Group 1A consisted of children who were on ART while 
Group 1B consisted of children who were not on ART. The ART 
was provided by a qualified pediatrician at ASHA Foundation 
as per National Guidelines. Group 2 consisted of exposed but 
uninfected children. Exposed, uninfected children are children with 
either one or both parents infected with HIV. Group 3 consisted of 
HIV-negative children unexposed to HIV, with both parents HIV 
negative. The CLHIV of Group 1 were all diagnosed HIV positive 
based on three positive HIV antibody tests performed on each 
child as per the national guidelines. The children of Group 2 and 
Group 3 were tested with a single HIV antibody test which was 
performed with consent and all these children were HIV negative. 
Ethical approval was obtained from the Research Advisory Board 
of ASHA Foundation. An informed consent form was developed 
and duly signed by a parent/guardian of the child, along with the 
investigator’s and witness’s signatures. Only trained research staff 
obtained informed consent with a necessary explanation to the 
parent/guardian. A well-validated questionnaire was used to assess 
the socioeconomic status [5]. These details included a question on 
prior exposure to tuberculosis.
The nutritional growth and development were assessed as 
follows: Height and weight were recorded using the standard 
height scale and digital weighing machine and were analyzed 
using standard growth charts for height, weight, and body mass 
index (BMI), for Indian boys and girls as published by the 
Indian Academy of Pediatrics [6]. The macro add-in devised by 
Dr. Khadilkar et al. in 2009 was obtained with his consent and 
used to determine the Z scores and percentiles. The nutritional 
parameters were measured at baseline and every 6 months for 
Group 1, at baseline and at 1 year for Group 2 and at baseline for 
Group 3. Sexual development was assessed using the Tanner’s 
Sexual Maturity Rating Scale [7]. The parameters were assessed 
at baseline and at 1st and 2nd year for Group 1, at baseline and at 
1 year for Group 2 and at baseline for Group 3.
Laboratory tests included estimation of hemoglobin, and 
total protein and serum albumin, to assess malnutrition, which 
can be an independent negative factor, although linked to HIV 
in our study children. Since anemia was a common feature of 
CLHIV, due to malnutrition, infection, infestation, stage of 
HIV/immunodeficiency, inflammation [2,8-11] and/or due to the 
use of zidovudine, annual hemograms were performed for CLHIV 
only. The other children had baseline hemoglobin estimation. The 
hemoglobin levels were classified using the table in the WHO 
manual on diagnosis and assessment of anemia [12] in children. 
As hypergammaglobulinemia was known to occur in CLHIV [13] 
which caused an increase in total protein, serum albumin was 
estimated to compare the groups for their nutritional status.
All details regarding inter-current infections, including 
respiratory and gastrointestinal, were collected at baseline and 
every 6 months in Group 1, at baseline and at 1 year in Group 2 
and at baseline in Group 3. All data were collected on paper 
clinical pro forma, checked, and entered by research coordinator 
into the database on Microsoft Excel sheets, on an ongoing basis.
On completion of enrollment and follow-up, data were analyzed 
using SPSS 15.0, Microsoft Excel, and SAS 9.2. Descriptive data 
were summarized and compared between Groups 1, 2, and 3; and 
also between Group 1A, 1B, 2 and 3. All tests were two-sided, 
and the p value for main effect was set at 0.05 and in the case of 
multiple comparisons adjusted using the Bonferroni correction; and 
the p value for interaction was set at 0.10. Evaluation of the shape 
of the distribution to check for “normality” was conducted and 
appropriate non-parametric tests were applied when the distribution 
was not Gaussian. Comparison between groups was performed 
using the Student’s t-test or ANOVA for unpaired data, paired t-test 
for paired data, the Fisher’s exact test, or a Chi-square contingency 
analysis where appropriate. Stratified data analysis was performed 
based on baseline characteristics such as age, gender, and BMI. 
Microsoft Word and Excel was used to generate graphs, tables, etc. 
Descriptive and inferential statistical analysis was performed in 
this study. Results on continuous measurements were presented by 
mean±standard deviation, and results on categorical measurements 
were presented in number (%). Significance was assessed at 5% 
level of significance. The frequency intervals and type of data 
variables collected during the study period are depicted in Table 1.
RESULTS
The total number of children enrolled for the study was 231 as 
demonstrated in Fig. 1 Group 1 consisted of 63 HIV-infected Figure 1: The distribution of the children among the three groups
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children. Of these, 32 were on ART and designated as Group 1A, 
and 31 were not on ART (1B). Group 2 consisted of 98 exposed 
but uninfected children while Group 3 consisted of 70 unexposed, 
HIV negative children. There was no death among the children 
during the study period. In Group 1A, three children missed one 
follow-up visit out of five. In Group 1B, five children were lost 
to follow-up and were not included in the final analysis. Three 
children missed one follow-up visit. One child from Group 2 
was lost to follow-up. All demographic details are summarized 
in Table 2.
There was no statistically significant difference between 
ages, gender, schooling, religion, and socioeconomic status 
among the three groups. Statistically significant difference 
was noted in prior exposure to tuberculosis, and parents alive/
dead between Group 1 and Group 3. Statistically significant 
difference was demonstrated between Group 1 and Group 2 
regarding mothers alive/dead, (33.3% vs. 7.1%) and Group 1 and 
Group 3 (33.3% vs. 2.9%). More number of children lost their 
fathers in Groups 1 and 2 when compared to Group 3 (49.2%, 
41.8%, and 2.9%). This was expected as the fathers were HIV 
positive. As demonstrated in Table 2, Groups 1 and 2 had 62% 
and 59.2 % of children exposed to TB as compared to 15.7% in 
Group 3.
Fig. 2 and Table 3 revealed that according to weight for age Z 
scores, 28.1% of children were underweight (Z score <−2) among 
Group 1, 12.5% among Group 2, and 14.3% among Group 3. 
Difference between Groups 1 and 2 demonstrated statistical 
significance (p=0.016). The serial weight for age means Z scores 
for the children in Group 1 had not demonstrated a significant 
difference between the five measurements and the mean Z scores 
were −1.38, −1.32, −1.28, −1.32, and −1.32. This was confirmed 
by the Friedman test (p=0.405). Comparison with the baseline 
and second semiannual values for Group 2 revealed that Group 1 
children did more poorly with no recovery in weight gain.
For height for age Z scores, 29.8% were stunted (Z score <−2) 
among Group 1, 16.7% among Group 2, and 11.4% among 
Group 3. Between Groups 1 and 3, there was statistical significance 
(p=0.010). There was no significant difference between CLHIV in 
Group 1A and Group 1B, with regard to weight for age or height 
for age Z scores. The serial height for age mean Z scores for the 
children in Group 1 revealed no significant difference between 
the five measurements, and the mean Z scores were −1.41, −1.41, 
−1.37, −1.38, and −1.42 (Friedman test p=0.365). Comparison 
with the baseline and second semiannual values in Group 2 again 
revealed no gain in height in the infected children to catch up with 
Group 2. BMI Z scores demonstrated no difference statistically 
between the three groups.
As demonstrated in Table 4, statistically significant 
difference was seen in Tanners Sexual Maturity Scale between 
Groups 1 and 3, and between Groups 1 and 2 at baseline. The 
Tanners Scale showed only 69.8% children with appropriate 
sexual maturity in Group 1, compared to 94.9% and 90% in 
Group 2 and 3, respectively. There was a significant difference 
(p<0.001) at baseline. 1 year later, 89.7% of the children in 
Group 1 had appropriate sexual maturity compared to 97.9% in 
Group 2, and the p value was no longer as significant changing 
from <0.001 to 0.011 during the same period.
Analysis of serum albumin demonstrated that all the three 
groups had normal albumin levels (Group 1 - 4.20 g/dl±0.32 vs. 
Group 2 - 4.24 g/dl±0.36 vs. Group 3 - 4.39 g/dl±0.17). However, 
the mean serum albumin was lowest in Group 1, and highest 
in Group 3. The difference between the Groups was significant 
Table 1: The frequency intervals and type of data variables collected during the study period
Variables studied CLHIV (n=63) Age-sex matched HIV 
exposed uninfected 
controls (n=98)
Age-sex matched 
HIV unexposed 
uninfected 
controls (n=70)
On ART (n=32) Not on ART (n=31)
Nutritional parameters
Height, weight, BMI Semiannual Semiannual Baseline and annual Baseline
Tanner’s sexual maturity rating scale Baseline, second 
and fourth 
semiannual
Baseline, second and 
fourth semiannual
Baseline and annual Baseline
Laboratory tests
Total protein and albumin, hemoglobin, total 
lymphocyte count
Baseline Baseline Baseline Baseline
HIV disease characteristics
CD4+T cell count Semiannual Semiannual X X
Chest X-ray Baseline and as 
needed
Baseline and as 
needed
Baseline Baseline
WHO HIV staging; development of new OIsa, 
malignancies
Semiannual Semiannual X X
Clinical immune status
All infections in past 6 months, number of 
respiratory infections in past 6 months, number 
of gastrointestinal infections in past 6 months
Semiannual Semiannual Baseline and annual Baseline
OIs: Opportunistic infections, CLHIV: Children living with human immunodeficiency virus, BMI: Body mass index
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Variable n (%) p value; Chi-square 
between Group 1 and 
Group 2
p value; Chi-square 
between Group 1 and 
Group 3Group 1 (n=63, unless otherwise 
noted)
Group 2 (n=98, 
unless otherwise 
noted)
Group 3 (n=70, 
unless 
otherwise 
noted)
Age
<5 1 (1.6) 10 (10.2) 1 (1.4) χ2=4.87; p=0.181 χ2=1.83; p=0.609
5-10 27 (42.9) 38 (38.8) 38 (54.3)
11-15 26 (41.3) 34 (34.7) 24 (34.3)
>15 9 (14.3) 16 (16.3) 7 (10.0)
Gender
Males 34 (54) 42 (42.9) 35 (50.0) χ2=1.90; p=0.168 χ2=0.209; p=0.647
Females 29 (46) 56 (57.1) 35 (50.0)
Schooling
Current 63 (100) 96 (98.0) 70 (100) 1.000
(Fisher exact test)
1.000
(Fisher exact test)Discontinued 0 1 (1.0) 0
None 0 1 (1.0) 0
Languages
Kannada 25 (39.7) 37 (37.8) 9 (12.9) 0.397
(Fisher exact test)
<0.001a
(Fisher exact test)Tamil 14 (22.2) 31 (31.6) 31 (44.3)
Telugu 20 (31.7) 23 (23.5) 8 (11.4)
Hindi 0 0 7 (10)
English 1 (1.6) 0 0
Others 3 (4.8) 7 (7.1) 15 (21.4)
Religion p value (Group 1 and 2) p value (Group 1 and 3)
Hindu 50 (79.4) 68 (69.4) 48 (68.6) 0.265
(Fisher exact test)
0.132
(Fisher exact test)Muslim 0 1 (1.0) 4 (5.7)
Christian 13 (20.6) 29 (29.6) 18 (25.7)
Locality
Rural 20 (31.7) 27 (27.6) 0 χ2=0.326; p=0.568 χ2=26.20; p<0.001a
Urban 43 (68.3) 71 (72.4) 70 (100)
Mother’s occupation
Dead 21 (33.3) 7 (7.1) 2 (2.9) <0.001a
(Fisher exact test)
<0.001a
(Fisher exact test)Housewife 17 (27.0) 33 (33.7) 30 (42.9)
Unskilled 8 (12.7) 35 (35.7) 29 (41.4)
Skilled 13 (20.6) 20 (20.4) 9 (12.9)
Blue collar 3 (4.8) 3 (3.1) 0 
Unknown 1 (1.6) 0 0
Father’s occupation
Dead 31 (49.2) 41 (41.8) 2 (2.9) 0.440
(Fisher exact test)
<0.001a
(Fisher exact test)Unemployed 0 4 (4.1) 0
Unskilled 11 (17.5) 17 (17.3) 37 (52.9)
Skilled 18 (28.6) 32 (32.7) 28 (40)
Blue collar 0 2 (2.0) 0
Professional 2 (3.2) 1 (1.0) 0
Others 0 0 0
Unknown 1 (1.6) 1 (1.0) 3 (4.3)
Average monthly income
In a care home
INR<1,000
1 (1.6)
1 (1.6)
0
2 (2.0)
0
0
0.325
(Fisher exact test)
0.006a
(Fisher exact test)
INR 1,000-5,000 32 (51.8) 42 (42.9) 43 (61.4)
Table 2: Summary of demographic details of the three groups
(Contd...)
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28.8% in Group 2, and 14.3 % in Group 3. Significant difference 
was seen between Group 1A and Group 3 (χ2=9.06, p=0.028) and 
severe anemia was highest in Group 1A. Zidovudine-based ART 
regimen was associated with 1.7 times more anemia. There were 
mixed causes for anemia in our study with macrocytic, microcytic, 
and normocytic anemia in equal proportion.
The incidence of infections calculated per person-year of follow-up 
was 92.9% in Group 1A, 109.1% in Group 1B, 93.8% in Group 2, 
and 137.1% in Group 3. This was lower than expected in Group 1A 
and 1B because the children were on prophylactic cotrimoxazole. 
The majority of infections which occurred in Groups 1A and 1B were 
severe in nature, such as herpes zoster, chickenpox, fungal infection, 
perianal abscess, pyoderma, and hepatitis, whereas the infections in 
Group 3 were mild upper respiratory infections which were counted 
and reported by the parents. Also for the children in Groups 1A and 
1B the infections were documented by the pediatrician, whereas for 
children in Groups 2 and 3 it was the parents who provided the input 
regarding infections.
Table 2: (Continued)
Figure 2: Anthropometric measurements showing stunted and 
underweight children in all three groups
(p=0.001). The difference between Group 1B (4.10±0.31) and 3 
was the most significant (p≤0.001).
Anemia was highest in Group 1. On further sub-analysis, 
anemia was highest in Group 1A, being 38.7%; 35.8% in Group 1B, 
Variable n (%) p value; Chi-square 
between Group 1 and 
Group 2
p value; Chi-square 
between Group 1 and 
Group 3Group 1 (n=63, unless otherwise 
noted)
Group 2 (n=98, 
unless otherwise 
noted)
Group 3 (n=70, 
unless 
otherwise 
noted)
INR 5,000-10,000 19 (30.2) 42 (42.9) 27 (38.6)
INR 10,000-25,000 6( 9.5) 7 (7.1) 0
INR 25,000-50,000 2 (3.2) 0 0
Unknown 2 (3.2) 5 (5.1) 0
Prior exposure to TB p value (Group 1 and 2) p value (Group 1 and 3)
Yes 39 (62.0) 58 (59.2) 11 (15.7) 0.614
(Fisher exact test)
<0.001a
(Fisher exact test)No 23 (36.5) 35 (35.7) 59 (84.3)
Unknown 1 (1.6) 5 (5.1) 0
Socioeconomic status n=55 (%) n=52 (%) n=37 (%) p value p value
Upper middle class 6 (10.9) 6 (11.5) 1 (2.7) χ2=0.0392; p=0.981 χ2=4.06; p=0.131
Lower middle class 38 (69.1) 35 (67.3) 23 (62.2)
Poor 11 (20.0) 11 (21.2) 13 (35.1)
Type of delivery n=58 (%) n=97 (%) n=70(%)
Normal 47 (81.0) 64 (66.0) 65 (92.9) χ2=8.15; p=0.004 χ2=1.28; p=0.257
Forceps 0 1 (1.0) 2 (2.9)
Cesarean 5 (8.6%) 28 (28.9) 3 (4.3)
Unknown 6 (10.3%) 4 (4.1) 0
Immunization summary
Fully immunized 15 (23.8) 22 (22.4) 15 (21.4) 0.806
(Fisher exact test)
0.039a
(Fisher exact test)Partially immunized 43 (68.3) 68 (69.4) 53 (75.7)
Not immunized 0 2 (2.0) 2 (2.9)
Unknown 5 (7.9) 6 (6.1) 0
Parents dead/alive
Mothers dead 21 (33.3) 7 (7.1) 2 (2.9) χ2=18.80; p<0.001a χ2=22.00; p<0.00a
Mothers alive 41 (65.1) 91 (92.9) 68 (97.1)
Unknown for both parents 1 (1.6) 0 0
Fathers dead 31 (49.2) 41 (41.8) 2 (2.9) χ2=1.02; p=0.312 χ2=39.00; p<0.00a
Fathers alive 31 (49.2) 57 (58.2) 68 (97.1)
aSignificant difference in findings between the groups. TB: Tuberculosis
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DISCUSSION
The data available from the Isanaka study reveal that HIV 
infection had long-lasting effects on both height and weight 
throughout infancy and childhood [1]. It was a review of 32 
articles published on post natal growth in HIV-infected children 
both in developed (USA, Western Europe) and underdeveloped 
countries (Sub-Saharan Africa). This occurred in spite of access 
to supplemental feeding and ART in developed countries. The 
differences in weight for age and height for age became obvious 
at the same time. In our study also, a significant number of 
CLHIV were underweight and stunted, which did not improve 
over time, with or without ART. More than a quarter children in 
Group 1 were underweight and it was significantly more than 
those in Group 2. Similarly, almost double the children (28.1%) 
in Group 1 are underweight than in Group 3 (14.3%); however, 
this was not statistically significant. This could be because the 
numbers of children in the study were small. There was no 
significant difference between Group 2 and Group 3.
With regard to height for age, almost 30% of children in 
Group 1 were stunted, and this was significantly more than in those 
in Group 3. All 10 studies from less developed countries, which 
were mostly in Sub-Saharan Africa, reported significantly lower 
weight for age in CLHIV than in exposed uninfected children [1]. 
In the five serial measurements of height in this group also, the 
decrease in height for age persisted. Possible mechanisms for 
this concomitant occurrence include HIV-related disturbances to 
energy balance, gastrointestinal disturbance and malabsorption, 
and neuroendocrine changes [1].
Grinspoon et al. [14] reported that this deficient physical 
development was probably due to a number of factors such as 
inadequate intake, malabsorptive disorders, metabolic alterations, 
hypogonadism, and excessive cytokine production. The increased 
metabolism in CLHIV required 10% more to maintain growth 
in asymptomatic CLHIV and 20-30% more in symptomatic 
CLHIV [14]. When CLHIV show weight loss, the energy 
requirement may increase by further 50-100% over established 
requirements for otherwise healthy uninfected children [15]. 
Poverty and ill health prevent parents from earning and providing 
food and nutrition for their children and this increased nutritional 
need widens the gap between the nutritional needs of CLHIV and 
the nutrition provided by their parents.
The BMI is lower in HIV-infected children compared to those 
in Group 2; though, it was not statistically significant. This was 
similar to findings in another study which demonstrated that 
HIV-infected infants revealed a trend toward lower values in 
Table 3: Distribution of anthropometric measurement Z scores
Anthropometric 
measurements
Group 1 (n=57) (%) Group 2 (n=96) (%) Group 3 (n=70) (%) p value
Chi-square test 
between Group 1 
and 2
p value
Chi-square between 
Group 1 and 3
WAZ
<−2 (underweight) 16 (28.1) 12 (12.5) 10 (14.3) χ2=5.80
p=0.016a
χ2=3.67
p=0.056>−2 41 (71.9) 84 (87.5) 60 (85.7)
HAZ
<−2 (stunted) 17 (29.8) 16 (16.7) 8 (11.4) χ2=3.66
p=0.056
χ2=6.72
p=0.010a>−2 40 (70.2) 80 (83.3) 62 (88.6)
BMIZ
<−2 2 (3.5) 4 (4.2) 6 (8.6) Pierson χ2 between 
groups ‑ χ2=2.070, 
p=0.355
>−2 55 (96.5) 92 (95.8) 64 (91.4)
aSignificant difference in findings between the groups. BMI: Body mass index
Table 4: The tanners sexual maturity staging at baseline and at one year for the three groups
Tanners sexual maturity staging – Baseline N=63 (%) N=98 (%) N=70 (%) p value
Between Group 1 & 3
p value
Between Group 1 & 2
Appropriate 44 (69.8) 93 (94.9) 63 (90.0) <0.001a
Fisher exact test
<0.001a
Fisher exact test
Less than appropriate 18 (28.6) 3 (3.1) 3 (4.3)
More than appropriate 1 (1.6) 2 (2.0) 4 (5.7)
Tanners sexual maturity staging at one year N=58 (%) N=97 (%) N (%) p value p value
Appropriate 52 (89.7) 95 (97.9) - 0.011a
Fisher exact test
-
Less than appropriate 6 (10.3) 1 (1.0) -
More than appropriate 0 1 (1.0)
aSignificant difference in findings between the group
Vol 4 | Issue 2 | Apr - Jun 2017 Indian J Child Health 168
Alexander et al. Growth and development of children living with human immunodeficiency virus
BMI and that this could be evident at birth itself [16]. Physical 
underdevelopment in children was not just in terms of height and 
weight but also in sexual development especially with regard to 
secondary sexual characteristics. According to Isanaka et al. [1], 
evaluation of the effect of HIV infection on adolescent growth 
and development should also remain a research priority. Advances 
in the management of HIV meant that many perinatally infected 
children reached adolescence. To date, only a small number of 
studies have examined the effect of HIV on adolescent growth 
and pubertal development.
This study also revealed that CLHIV had delayed onset of 
sexual maturity at baseline but made up over time. Only 69.8% of 
the CLHIV had appropriate sexual maturity for age and this had 
risen to 89.7% after 1 year suggesting that sexual maturity was 
delayed but eventually reached for the most children. A large study 
for the International Maternal Pediatric and Adolescent AIDS 
Clinical Trials P219/219C Study and the Pediatric HIV/AIDS 
Cohort Study done on 2086 youth comparing CLHIV with 
HIV-exposed but uninfected children demonstrated that there was 
pubertal delay in the infected group by about 4-13 months and 
this pubertal delay was reduced by giving ART [17]. One study 
referred to children being affected psychologically because their 
height, weight, and secondary sexual characteristics were not as 
well developed as in their peer [18].
With regard to albumin levels, CLHIV not yet on ART had 
the lowest mean serum albumin compared to exposed children 
and unexposed uninfected children. The mean serum albumin 
level was within normal limits in all three groups. However, the 
highest mean was seen in Group 3 and the lowest in Group 1. On 
comparing Groups 1A, 1B, 2 and 3, it was found that Group 1B 
had the lowest level. It is probable that this was because children 
who were HIV positive and not on ART were not given priority to 
receive high-protein diet at home, like those who were known to 
be HIV positive and receiving ART.
Malnutrition has a multifactorial contribution. Even exposed 
children compared with unexposed children in Zambia [19] had 
lower anthropometry pointing to other socioeconomic factors in 
families of persons living with HIV. This was also seen in our 
study, in which a lower serum albumin is noted among the exposed 
children compared to the unexposed. Families living with HIV 
have multiple financial needs, poor health-seeking behavior, and 
increased metabolic demands due to HIV, intercurrent illness, and 
possibly some alterations in metabolic and endocrine function. 
These alterations in metabolic and endocrine function may be due 
to the primary infection itself or due to the medication. Reducing 
the viral load in these patients helps in improvement of the 
anthropometric indices [20]. The intense dietary counseling, drug 
subsidies and dry ration handouts received by those at risk help 
them, as the study in Tanzania shows where supply of ready-to-
use foods was made available [21].
The hemoglobin levels were lowest in CLHIV on ART 
(Group 1A). The etiology of anemia in CLHIV was varied and 
included iron deficiency, anemia of inflammation, vitamin B 
deficiency, ART itself, a decrease in red cell precursors in bone 
marrow, associated hookworm infestation; and thalassemia/
thalassemia trait and falciparum malaria in other regions of 
Asia [2,7-10]. Some of the pathophysiology was still not understood 
well [9]. Grinspoon et al. [14] identified certain criteria to define 
growth failure in CLHIV. Similar criteria are needed to establish 
Indian guidelines for monitoring physical growth, intellectual 
growth, emotional growth, and sexual maturity to identify 
those children who need additional counseling; micronutrients 
combined with earlier ART [8] and other nutritional supplements 
to prevent their developmental retardation.
CONCLUSION
This study shows that CLHIV are comparatively more stunted and 
have decreased weight for age, delayed sexual maturation, and 
more significant anemia when compared to exposed uninfected 
children and unexposed uninfected children. This physical growth 
retardation is not reversed completely by addition of ART.
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